Strategies for the Commercialization of Psychedelics: For-profit vs. Not For-profit

Lewis Goldberg
03 Apr 2020
13:00 - 13:50
Main Room

Strategies for the Commercialization of Psychedelics: For-profit vs. Not For-profit

As mushrooms get decriminalized in Oakland and Denver, numerous experts are suggesting the plant could be a promising treatment for depression. While it isn’t in the cannabis family, it is considered a mind-altering substance and has some crossover within the cannabis industry. Many are suggesting it compliment the cannabis industry growth. This panel will take a look at this fast-growing industry and what the future holds for it.